| Literature DB >> 22919512 |
Rokeia Eltheni1, Konstantinos Giakoumidakis, Hero Brokalaki, Petros Galanis, Ioannis Nenekidis, George Fildissis.
Abstract
The prediction of intensive care unit length of stay (ICU-LOS) could contribute to more efficient ICU resources' allocation and better planning of care among cardiac surgery patients. The aim of this study was to identify the preoperative and intraoperative predictors for prolonged cardiac surgery ICU-LOS. An observational cohort study was conducted among 150 consecutive patients, who were admitted to the cardiac surgery ICU of a tertiary hospital of Athens, Greece from September 2010 to January 2011. Multivariate regression analysis revealed that patients with increased creatinine levels preoperatively (odds ratio (OR) 3.0, P = 0.049), history of atrial fibrillation (AF) (OR 6.3, P = 0.012) and high EuroSCORE values (OR 2.6, P = 0.017) had a significant greater probability to stay in the ICU for more than 2 days. In addition, intraoperative hyperglycemia (OR 3.0, P = 0.004) was strongly associated with longer ICU-LOS. In conclusion, the high perioperative risk, the history of AF and renal dysfunction, and the intraoperative hyperglycemia are significant predictors of prolonged ICU stay. The early identification of patients at risk could allow the efficient ICU resources' allocation and the reduction of healthcare costs. This would contribute to nursing care planning depending on the availability of healthcare personnel and ICU bed capacity.Entities:
Year: 2012 PMID: 22919512 PMCID: PMC3394383 DOI: 10.5402/2012/691561
Source DB: PubMed Journal: ISRN Nurs ISSN: 2090-5483
Demographic and perioperative sample characteristics.
|
| Median (IR) | |
|---|---|---|
| Gender | ||
| Male | 102 (68.0) | |
| Female | 48 (32.0) | |
| Age (years) | 66 (15) | |
| ≤66 | 78 (52.0) | |
| >66 | 72 (48.0) | |
| BMI | 27.6 (8.4) | |
| Normal | 49 (32.7) | |
| Overweight/obese | 101 (67.3) | |
| Chronic pulmonary disease | ||
| No | 123 (82.0) | |
| Yes | 27 (18.0) | |
| Diabetes | ||
| No | 101 (67.3) | |
| Yes | 49 (32.7) | |
| Type of surgery | ||
| Coronary artery bypass grafting (Type I) | 67 (44.7) | |
| Valve disease repair (Type II) | 41 (27.3) | |
| Aorta aneurysm repair | 17 (11.3) | |
| Types I and II | 18 (12.0) | |
| Other∗ | 7 (4.6) | |
| Preoperative serum Cr (mg/dL) | 1 (0.4) | |
| ≤1.4 | 124 (82.7) | |
| >1.4 | 26 (17.3) | |
| Mean intraoperative blood glucose (mg/dL) | 130 (36) | |
| ≤130 | 78 (52.0) | |
| >130 | 72 (48.0) | |
| Preoperative IABP | ||
| No | 146 (97.3) | |
| Yes | 4 (2.7) | |
| CPB | ||
| No | 16 (10.7) | |
| Yes | 134 (89.3) | |
| EFLV (%) | 55 (15) | |
| ≤55 | 105 (70.0) | |
| >55 | 45 (30.0) | |
| Duration of surgery (min) | 250 (110) | |
| ≤250 | 76 (50.7) | |
| >250 | 74 (49.3) | |
| Duration of CPB (min) | 125 (69) | |
| ≤125 | 76 (50.7) | |
| >125 | 74 (49.3) | |
| Preoperative AF | ||
| No | 133 (88.7) | |
| Yes | 17 (11.3) | |
| Emergency | ||
| No | 135 (90.0) | |
| Yes | 15 (10.0) | |
| Ischemic time (min) | 78 (54) | |
| ≤78 | 76 (50.7) | |
| >78 | 74 (49.3) | |
| RBC | ||
| No | 96 (64.0) | |
| Yes | 54 (36.0) | |
| Logistic EuroSCORE (%) | 5.4 (7.3) | |
| ≤5.4 | 75 (50.0) | |
| >5.4 | 75 (50.0) | |
| 30-day mortality | ||
| Alive | 130 (86.7) | |
| Nonalive | 20 (13.3) | |
| ICU-LOS (days) | 2 (3) | |
| ≤2 | 76 (50.7) | |
| >2 | 74 (49.3) |
AF: atrial fibrillation, BMI: body mass index, CPB: cardiopulmonary bypass, Cr: creatinine, EFLV: ejection fraction of the left ventricle, EuroSCORE: European system for cardiac operative risk evaluation, IABP: intraaortic balloon pump, ICU: intensive care unit, LOS: length of stay, RBCs: red blood cells.
∗Another category refers to 7 patients who have undergone the closure of an atrial septal defect or a valve surgery in conjunction with aorta aneurysm repair.
Bivariate analysis between the ICU-LOS and independent variables.
| ICU-LOS (days) |
| ||
|---|---|---|---|
| ≤2 | >2 | ||
|
|
| ||
| Gender | 0.48∗ | ||
| Male | 51 (50.0) | 51 (50.0) | |
| Female | 27 (56.3) | 21 (43.8) | |
| Age (years) | 0.89∗ | ||
| ≤66 | 41 (52.6) | 37 (47.4) | |
| >66 | 37 (51.4) | 35 (48.6) | |
| BMI | 0.22∗ | ||
| Normal | 29 (59.2) | 20 (40.8) | |
| Overweight/obese | 49 (48.5) | 52 (51.5) | |
| Chronic pulmonary disease | 0.2∗ | ||
| No | 67 (54.5) | 56 (45.5) | |
| Yes | 11 (40.7) | 16 (59.3) | |
| Diabetes | 0.6∗ | ||
| No | 54 (53.5) | 47 (46.5) | |
| Yes | 24 (49.0) | 25 (51.0) | |
| Type of surgery | 0.06∗ | ||
| Coronary artery bypass grafting (Type I) | 40 (59.7) | 27 (40.3) | |
| Valve disease repair (Type II) | 23 (56.1) | 18 (43.9) | |
| Aorta aneurysm repair | 6 (35.3) | 11 (64.7) | |
| Types I and II | 5 (27.8) | 13 (72.2) | |
| Other∗∗∗ | 4 (57.1) | 3 (42.9) | |
| Preoperative serum Cr (mg/dL) | 0.005* | ||
| ≤1.4 | 71 (57.3) | 53 (42.7) | |
| >1.4 | 7 (26.9) | 19 (73.1) | |
| Mean intraoperative blood glucose (mg/dl) | 0.002* | ||
| ≤130 | 50 (64.1) | 28 (35.9) | |
| >130 | 28 (38.9) | 44 (61.1) | |
| Preoperative IABP | 0.05** | ||
| No | 78 (53.4) | 68 (46.6) | |
| Yes | 0 (0.0) | 4 (100.0) | |
| CPB | 0.72∗ | ||
| No | 9 (56.3) | 7 (43.8) | |
| Yes | 69 (51.5) | 65 (48.5) | |
| EFLV | 0.1∗ | ||
| ≤55 | 50 (47.6) | 55 (52.4) | |
| >55 | 28 (62.2) | 17 (37.8) | |
| Duration of surgery (min) | 0.002* | ||
| ≤250 | 49 (64.5) | 27 (35.5) | |
| >250 | 29 (39.2) | 45 (60.8) | |
| Duration of CPB (min) |
| ||
| ≤125 | 51 (67.1) | 25 (32.9) | |
| >125 | 27 (36.5) | 47 (63.5) | |
| Preoperative AF | 0.003* | ||
| No | 75 (56.4) | 58 (43.6) | |
| Yes | 3 (17.6) | 14 (82.4) | |
| Emergency | 0.002* | ||
| No | 76 (56.3) | 59 (43.7) | |
| Yes | 2 (13.3) | 13 (86.7) | |
| Ischemic time (min) | 0.073∗ | ||
| ≤78 | 45 (59.2) | 31 (40.8) | |
| >78 | 33 (44.6) | 41 (55.4) | |
| RBC | 0.016* | ||
| No | 57 (59.4) | 39 (40.6) | |
| Yes | 21 (38.9) | 33 (61.1) | |
| Logistic EuroSCORE (%) |
| ||
| ≤5.4 | 52 (69.3) | 23 (30.7) | |
| >5.4 | 26 (34.7) | 49 (65.3) | |
AF: atrial fibrillation, BMI: body mass index, CPB: cardiopulmonary bypass, Cr: creatinine, EFLV: ejection fraction of the left ventricle, EuroSCORE: European system for cardiac operative risk Evaluation, IABP: intraaortic balloon pump, ICU: intensive care unit, LOS: length of stay, RBCs: red blood cells.
∗Chi-square test
∗∗Fisher's exact test
∗∗∗Another category refers to 7 patients who have undergone the closure of an atrial septal defect or a valve surgery in conjunction with aorta aneurysm repair.
Logistic regression analysis (odds ratios and 95% confidence intervals) with ICU-LOS as dependent variable.
| ICU-LOS (days) | ||||
|---|---|---|---|---|
| Crude OR (95% CI) |
| Adjusted∗ OR (95% CI) |
| |
| Preoperative serum Cr (mg/dL) | 0.007 |
| ||
| ≤1.4 | 1.0 | 1.0 | ||
| >1.4 | 3.6 (1.4–9.3) | 3.0 (1.0–8.7) | ||
| Mean intraoperative blood glucose (mg/dL) | 0.002 |
| ||
| ≤130 | 1.0 | 1.0 | ||
| >130 | 2.8 (1.5–5.4) | 3.0 (1.4–6.4) | ||
| Preoperative AF | 0.006 |
| ||
| No | 1.0 | 1.0 | ||
| Yes | 6.0 (1.7–22.0) | 6.3 (1.5–26.4) | ||
| Logistic EuroSCORE (%) | <0.001 |
| ||
| ≤5.4 | 1.0 | 1.0 | ||
| >5.4 | 4.3 (2.2–8.4) | 2.6 (1.2–5.6) | ||
AF: atrial fibrillation, CI: confidence interval, Cr: creatinine, EuroSCORE: European system for cardiac operative risk evaluation, ICU: intensive care unit, LOS: length of stay, OR: odds ratio.
∗Adjusted for gender, age, BMI, chronic pulmonary disease, diabetes, type of surgery, preoperative IABP, CBP, EFLV, duration of surgery, duration of cardiopulmonary bypass, emergency, ischemic time, and RBC.